Bouchey Financial Group Ltd - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bouchey Financial Group Ltd ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$220,385
-1.6%
5,5000.0%0.03%
-10.0%
Q1 2023$224,000
+5.5%
5,5000.0%0.03%
-3.2%
Q4 2022$212,355
-27.5%
5,5000.0%0.03%
-27.9%
Q3 2022$293,000
-8.7%
5,5000.0%0.04%
-15.7%
Q2 2022$321,000
-23.6%
5,5000.0%0.05%
-8.9%
Q1 2022$420,000
+26.9%
5,5000.0%0.06%
+27.3%
Q4 2021$331,000
+7.5%
5,5000.0%0.04%
+2.3%
Q3 2021$308,000
-7.8%
5,5000.0%0.04%
-18.9%
Q2 2021$334,000
-13.2%
5,5000.0%0.05%
-14.5%
Q1 2021$385,000
+43.1%
5,500
+22.2%
0.06%
+34.8%
Q4 2020$269,000
-0.7%
4,5000.0%0.05%
-11.5%
Q3 2020$271,000
+14.8%
4,5000.0%0.05%
+4.0%
Q2 2020$236,000
+15.7%
4,5000.0%0.05%
+6.4%
Q4 2019$204,000
-7.7%
4,5000.0%0.05%
-13.0%
Q3 2018$221,000
+7.8%
4,5000.0%0.05%
-8.5%
Q4 2017$205,000
-14.9%
4,500
-1.1%
0.06%
-42.2%
Q1 2016$241,000
-30.9%
4,5500.0%0.10%
-32.5%
Q4 2015$349,000
+9.7%
4,550
+1.1%
0.15%
+11.0%
Q2 2015$318,000
-42.3%
4,500
-27.4%
0.14%
-45.2%
Q1 2015$551,000
-4.3%
6,200
-4.6%
0.25%
-8.5%
Q4 2014$576,000
+32.1%
6,500
+44.4%
0.27%
+22.6%
Q3 2014$436,000
-20.9%
4,500
-25.0%
0.22%
-25.1%
Q2 2014$551,000
+31.2%
6,0000.0%0.30%
+15.7%
Q1 2014$420,000
+7.7%
6,0000.0%0.26%
-7.3%
Q4 2013$390,0006,0000.28%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders